IGF2BP3 recruits the deubiquitinase USP10 thereby attenuating p53 protein stability and increasing tumorigenicity of lung cancer cells in vivo (Zhao et al., 2017). The gene discussed is IGF2BP3; the disease is lung carcinoma.